Myriad Receives FDA Approval of myChoice CDx® as Companion Diagn

看多

Myriad Genetics, Inc. (NASDAQ:MYGN)

NASDAQ:MYGN Myriad Genetics, Inc.

beyondta

MYGN: Myriad Genetics, Inc.
2020-05-11 07:05:10
Myriad Receives FDA Approval of myChoice CDx® as Companion Diagnostic for Lynparza™ (olaparib) In Patients with Advanced Ovarian Cancer

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。